tiprankstipranks
Repare Therapeutics reports ‘positive’ results from MYTHIC Phase 1 trial
PremiumThe FlyRepare Therapeutics reports ‘positive’ results from MYTHIC Phase 1 trial
9d ago
Repare Therapeutics announces CRADA to advance camonsertib development
Premium
The Fly
Repare Therapeutics announces CRADA to advance camonsertib development
1M ago
Repare Therapeutics Reports Q3 2024 Progress and Outlook
Premium
Company Announcements
Repare Therapeutics Reports Q3 2024 Progress and Outlook
1M ago
Repare: Endometrial cancers with CCNE1 amplifications carry poor prognosis
PremiumThe FlyRepare: Endometrial cancers with CCNE1 amplifications carry poor prognosis
3M ago
Repare Therapeutics Announces Strategic R&D Focus and Workforce Reduction
Premium
Company Announcements
Repare Therapeutics Announces Strategic R&D Focus and Workforce Reduction
4M ago
Repare announces strategic reprioritization, to lay off 25% of workforce
Premium
The Fly
Repare announces strategic reprioritization, to lay off 25% of workforce
4M ago
Repare Therapeutics reports Q2 EPS (82c), consensus (87c)
PremiumThe FlyRepare Therapeutics reports Q2 EPS (82c), consensus (87c)
5M ago
Repare Therapeutics management to meet virtually with Piper Sandler
Premium
The Fly
Repare Therapeutics management to meet virtually with Piper Sandler
5M ago
Repare Therapeutics announces intial data from Phase 1 MINOTAUR trial
Premium
The Fly
Repare Therapeutics announces intial data from Phase 1 MINOTAUR trial
6M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100